The Thierry Latran Foundation 12th Call for projects opened in December 2019 The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and b)...
The Thierry Latran Foundation 11th Call for projects opened in October 2018 The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and b)...
The Thierry Latran Foundation 10th Call for projects opened in December 2017 The Thierry Latran Foundation was established in 2008 to a) finance basic, applied and clinical research with potential therapeutic benefit in sporadic ALS (Amyotrophic Lateral Sclerosis) and...
The Thierry Latran Foundation 9th Call for projects opened in November 2016 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies, innovative molecules in the fields...
The Thierry Latran Foundation 8th Call for projects opened in November 2015 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies, innovative molecules in the fields...
The Thierry Latran Foundation 7th Call for projects opened in November 2014 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies, innovative molecules in the fields...
6th Call for Projects: 2 New Selected Projects The sixth call for projects opened in November 2013 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies,...
SELECTION PROCESS The selection process is driven by the secretary of the Scientific Advisory Board. Abstract evaluation Each abstract will be rated by each member of the SAB independently following a defined methodology Each abstract will be evaluated...
The Thierry Latran Foundation wants to enhance basic, applied and clinical research with potential therapeutic benefit in sporadic Amyotrophic Lateral Sclerosis. The Foundation wants to encourage innovative approaches. The Scientific Advisory Board is responsible for the selection and...
The fifth call for projects opened in November 2012 to finance research with potential therapeutic benefit in sporadic ALS on the following themes: Biological markers, pathological pathways and mechanisms, therapeutic strategies, innovative molecules in the fields of ALS and...